SCHEMBL2328504

SCHEMBL2328504

OCc1ccccc1C1(O)CCCN(Cc2ccccc2)CC1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 4/20 0.70
POLB P06746 2/20 0.56
OPRM1 P35372 2/20 0.55
OPRD1 P41143 2/20 0.55
OPRK1 P41145 2/20 0.55
CCR3 P51677 1/20 0.52
SIGMAR1 Q99720 9/20 0.47
CYP3A4 P08684 3/20 0.47
DRD2 P14416 3/20 0.47
TP53 P04637 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2D6 P10635 2/20 0.47
TSHR P16473 2/20 0.47
CYP2C19 P33261 2/20 0.47
NFKB1 P19838 1/20 0.47
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
MAPK1 P28482 1/20 0.47
HTR2B P41595 1/20 0.47
MTOR P42345 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2360601 1.00 OPRL1 (0.70) OPRL1POLBOPRM1OPRD1OPRK1
SCHEMBL2877688 0.95 OPRL1 (0.77) OPRL1POLBOPRM1OPRD1OPRK1
SCHEMBL350525 0.86 OPRL1 (0.65) OPRL1POLBOPRM1OPRD1OPRK1
SCHEMBL2323985 0.84 OPRL1 (0.73) OPRL1POLBOPRM1OPRD1OPRK1
SCHEMBL11195174 0.83 OPRL1 (0.77) OPRL1POLBOPRM1CCR3SIGMAR1
Hydrochloric Acid SCHEMBL11193622 0.82 OPRL1 (0.75) OPRL1POLBOPRM1CCR3SIGMAR1
SCHEMBL6913288 0.82 OPRL1 (0.70) OPRL1POLBOPRM1OPRD1OPRK1
SCHEMBL6911078 0.80 OPRL1 (0.71) OPRL1POLBCCR3SIGMAR1CYP3A4
SCHEMBL12023243 0.80 OPRL1 (0.56) OPRL1POLBSIGMAR1CYP3A4DRD2
SCHEMBL2514218 0.80 OPRL1 (0.56) OPRL1POLBOPRM1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8664216-B2 Spiro-5,6-dihydro-4H-2,3,5,10b-tetraaza-benzo[e]azulenes HOFFMANN-LA ROCHE INC. (US) 2014-03-04 US disclosed
EP-2356123-B1 SPIRO-5,6-DIHYDRO-4H-2,3,5,10B-TETRAAZA-BENZO[E]AZULENES HOFFMANN LA ROCHE (CH) 2012-10-03 EP disclosed
EP-2356123-A1 SPIRO-5,6-DIHYDRO-4H-2,3,5,10B-TETRAAZA-BENZO[E]AZULENES F. Hoffmann-La Roche AG (CH) 2011-08-17 EP disclosed
WO-2010054961-A1 SPIRO-5,6-DIHYDRO-4H-2,3,5,10B-TETRAAZA-BENZO[E]AZULENES F. HOFFMANN-LA ROCHE AG (CH) 2010-05-20 WO disclosed
US-20100120751-A1 SPIRO-5,6-DIHYDRO-4H-2,3,5,10B-TETRAAZA-BENZO[E]AZULENES HOFFMANN-LA ROCHE, INC. 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120751-A1 SPIRO-5,6-DIHYDRO-4H-2,3,5,10B-TETRAAZA-BENZO[E]AZULENES AVPR1A, OXTR, AVPR1B OPRL1 10/4885POLB 3759/4885OPRM1 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.